These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18199479)

  • 1. Osteotropic beta-cyclodextrin for local bone regeneration.
    Liu XM; Wiswall AT; Rutledge JE; Akhter MP; Cullen DM; Reinhardt RA; Wang D
    Biomaterials; 2008 Apr; 29(11):1686-92. PubMed ID: 18199479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.
    Liu XM; Lee HT; Reinhardt RA; Marky LA; Wang D
    J Control Release; 2007 Sep; 122(1):54-62. PubMed ID: 17673326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of local and systemic alendronate on simvastatin-induced new bone around periodontal defects.
    Killeen AC; Rakes PA; Schmid MJ; Zhang Y; Narayana N; Marx DB; Payne JB; Wang D; Reinhardt RA
    J Periodontol; 2012 Dec; 83(12):1463-71. PubMed ID: 22420870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss.
    Price U; Le HO; Powell SE; Schmid MJ; Marx DB; Zhang Y; Wang D; Narayana N; Reinhardt RA
    J Periodontal Res; 2013 Oct; 48(5):541-8. PubMed ID: 23278592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss.
    Liu CC; Hu S; Chen G; Georgiou J; Arns S; Kumar NS; Young RN; Grynpas MD
    J Bone Miner Res; 2015 Apr; 30(4):670-80. PubMed ID: 25284325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.
    Wang CZ; Chen SM; Chen CH; Wang CK; Wang GJ; Chang JK; Ho ML
    Biomaterials; 2010 Nov; 31(33):8674-83. PubMed ID: 20719378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prostaglandin pathway and alendronate-based carriers to enhance statin-induced bone.
    Lee Y; Liu X; Nawshad A; Marx DB; Wang D; Reinhardt RA
    Mol Pharm; 2011 Aug; 8(4):1035-42. PubMed ID: 21438610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Alendronate Loaded Biphasic Calcium Phosphate Scaffolds on Bone Regeneration in a Rat Tibial Defect Model.
    Park KW; Yun YP; Kim SE; Song HR
    Int J Mol Sci; 2015 Nov; 16(11):26738-53. PubMed ID: 26561810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
    Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteotropic Peptide that differentiates functional domains of the skeleton.
    Wang D; Miller SC; Shlyakhtenko LS; Portillo AM; Liu XM; Papangkorn K; Kopecková P; Lyubchenko Y; Higuchi WI; Kopecek J
    Bioconjug Chem; 2007; 18(5):1375-8. PubMed ID: 17705416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.
    Hein CD; Liu XM; Chen F; Cullen DM; Wang D
    Macromol Biosci; 2010 Dec; 10(12):1544-56. PubMed ID: 20954201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin based bone regenerative inclusion complex for resveratrol in postmenopausal osteoporosis.
    Shah AA; Shah A; Lewis S; Ghate V; Saklani R; Narayana Kalkura S; Baby C; Singh PK; Nayak Y; Chourasia MK
    Eur J Pharm Biopharm; 2021 Oct; 167():127-139. PubMed ID: 34329710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.